(1)
Socio-Gerontological Perspectives on Disease-Modifying Alzheimer’s Therapies (Lecanemab): A Delphi Study in Central Europe. J. Heal. Rehab. Sci. 2026, 5 (1), 8-16. https://doi.org/10.33700/jhrs.5.1.222.